We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTPAW
12501
DELISTED
Gores Technology Partners, Inc. Warrant
GTPAW
$133K ﹤0.01%
+100,000
New +$107K
FOCL
12502
CALL
EDAP TMS S.A.
FOCL
$178M
$132K ﹤0.01%
18,600
-8,400
-31% -$61K
CBIO
12503
PUT
Crescent Biopharma
CBIO
$637M
$132K ﹤0.01%
570
+129
+29% +$32.8K
MYPS icon
12504
PUT
PLAYSTUDIOS Inc
MYPS
$63.1M
$132K ﹤0.01%
+17,800
New +$172K
ORGS
12505
PUT
DELISTED
Orgenesis Inc. Common Stock
ORGS
$132K ﹤0.01%
+2,610
New +$131K
TINV.U
12506
DELISTED
Tiga Acquisition Corp. Units, each consisting of one Class A ordinary share and one half of one warrant
TINV.U
$132K ﹤0.01%
12,518
-482
-4% -$5.08K
KLDO
12507
CALL
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$132K ﹤0.01%
17,800
-5,300
-23% -$37.6K
CTAC.U
12508
DELISTED
Cerberus Telecom Acquisition Corp. Units, each consisting of one Class A ordinary share and one-thir
CTAC.U
$132K ﹤0.01%
12,698
-5,518
-30% -$56.9K
AVAH icon
12509
CALL
Aveanna Healthcare
AVAH
$2.69B
$131K ﹤0.01%
+10,600
New +$126K
BTOG icon
12510
Bit Origin
BTOG
$3.41M
$131K ﹤0.01%
46
-35
-43% -$73.6K
NMR icon
12511
PUT
Nomura Holdings
NMR
$28.7B
$131K ﹤0.01%
+25,700
New +$138K
ORLA
12512
DELISTED
Orla Mining
ORLA
$131K ﹤0.01%
31,985
+1,754
+6% +$7.26K
WT icon
12513
PUT
WisdomTree
WT
$3.46B
$131K ﹤0.01%
21,200
+8,700
+70% +$57.4K
QTT
12514
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$131K ﹤0.01%
7,040
-2,586
-27% -$54.6K
CEMI
12515
PUT
DELISTED
Chembio diagnostics, Inc.
CEMI
$131K ﹤0.01%
44,200
+1,300
+3% +$4.53K
CABA icon
12516
PUT
Cabaletta Bio
CABA
$466M
$130K ﹤0.01%
+15,100
New +$148K
CLS icon
12517
PUT
Celestica
CLS
$42.3B
$130K ﹤0.01%
+16,500
New +$138K
GPRK icon
12518
GeoPark
GPRK
$615M
$130K ﹤0.01%
+10,296
New +$157K
PRPO icon
12519
PUT
Precipio
PRPO
$42M
$130K ﹤0.01%
+1,795
New +$118K
LMAOU
12520
DELISTED
LMF Acquisition Opportunities Inc. Unit
LMAOU
$130K ﹤0.01%
+12,454
New +$128K
OTRA
12521
DELISTED
OTR Acquisition Corp. Class A Common Stock
OTRA
$130K ﹤0.01%
+12,992
New +$130K
AIV
12522
PUT
Aimco
AIV
$383M
$129K ﹤0.01%
19,200
-14,700
-43% -$101K
CIFR icon
12523
Cipher Digital
CIFR
$7.41B
$129K ﹤0.01%
12,980
-67,450
-84% -$678K
EPM icon
12524
Evolution Petroleum
EPM
$135M
$129K ﹤0.01%
26,189
+11,483
+78% +$45.1K
JAGX icon
12525
PUT
Jaguar Health
JAGX
$4.5M
0

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.